Navigation Links
Particle Sciences and IES Engineers Cooperate on High Potency Compound Handling Capabilities
Date:12/8/2009

BETHLEHEM, Pa., Dec. 8 /PRNewswire/ -- Particle Sciences Inc. (PSI), a leading pharmaceutical CRO, has further expanded their High Potency Compound (HPC) handling capabilities through a unique relationship with IES Engineers. "HPCs are an increasing part of our business and an area that many CROs are unwilling to make the necessary investment in to safely handle them," says Dr. Robert Lee, PSI's VP Pharmaceutical Development. "Each HPC is different and requires its own set of considerations. Companies need both the physical and staffing infrastructure to work with them. For PSI, the key task was proper strategic staffing maximizing not only our ability to work with HPCs but to do it in a way that was commercially viable," Dr. Lee went on to say.

Under the arrangement, IES Engineers will be responsible for evaluating incoming materials and placing them into exposure control bands, which specify the safe procedures around their handling and processing. IES will also be involved in specific design and implementation of HPC related procedures. In this way, PSI gains the experience and vast capabilities of one of the world's leaders in potent compound safety. According to George Petroka, Director BioPharma/EHS Services at IES Engineers, "This is the standard approach adopted by big Pharma for working with HPCs, but is not as common outside of that group, and demonstrates PSI's dedication to working with HPCs and providing innovative HPC services. By using IES Engineers in this capacity, PSI is assuring their clients of industry-leading practices and careful review of procedures. It would be very difficult for a midsized company to acquire the level of expertise we can provide."

Dr. Lee further stated, "Our core areas are nano-based systems and difficult to formulate APIs both in semisolids and combination products. Obviously, a great number of these products are HPCs such as oncology agents and various hormone preparations. Expanding this capability only makes sense as we look for better ways to serve our client base."

IES is a fully integrated engineering and environmental, health, and safety consulting firm providing an extensive range of technical services to the bio/pharmaceutical, healthcare, specialty chemical, food, printing, and industrial sectors. Client speed to market, aggressive schedule deadlines, quality, regulatory compliance, and best management practices drive our project performance. As the consultant of choice, our primary focus is to improve our clients' financial performance and reduce liabilities while helping them maximize their competitive advantage.

Particle Sciences is an integrated provider of drug development services. Particle Sciences focuses on emulsions, gels, particulates and drug/device combination products with additional specialized capabilities in topical and mucosal drug delivery. Through a full range of formulation, analytic, and manufacturing services, Particle Sciences provides pharmaceutical companies with a complete and seamless development solution that minimizes the time and risk between discovery and the clinic. The company was founded in 1991 and is headquartered in Bethlehem, Pennsylvania. Visit http://www.particlesciences.com, email info@particlesciences.com or contact us at (610) 861-4701 for information.


Contact:
Maureen Cochran
mcochran@particlesciences.com

SOURCE Particle Sciences Inc.


'/>"/>
SOURCE Particle Sciences Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Targeted Nanoparticles Offer Promise in the Battle Against Cancer
2. IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
3. Recent Findings from the Framingham Offspring Study Show Low Numbers of LDL Particles (LDL-P) by NMR are Associated With Fewer Heart Disease Related Events than Equivalently Low Levels of LDL Cholesterol (LDL-C).(1)
4. Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations
5. Ion Mobility Diagnostic Test from Quest Diagnostics is First to Provide Direct Physical Measurement of Lipoprotein Particles, Cardiovascular Disease Indicators, Study Finds
6. Particle Sciences Expands Its Combination Product Capabilities
7. Novavax Reports Positive Preclinical Results for a Novel, Broadly Cross-Protective H5N1 Pandemic Influenza Virus-like Particle (VLP) Vaccine Candidate
8. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
9. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
10. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
11. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... YORK , December 2, 2016 ... Braces & Support) is Expected to Gain a Significant Market ... to Orthopedic Ailments  ... , According to ... Study on Medical Implants Sterile Packaging: Clamshell Product Type Segment ...
(Date:12/2/2016)... On Thursday, the NASDAQ Composite and ... the Dow Jones Industrial Average managed to stay in green. ... which prompted Stock-callers this morning to look at the performances ... NUVA ), Smith & Nephew PLC (NYSE: SNN ... Cesca Therapeutics Inc. (NASDAQ: KOOL ). You can ...
(Date:12/2/2016)... -- The concept of rare diseases and the idea that ... has been taking shape in Europe ... initiatives related to orphan medicinal products have been emerging at ... states individually. Many member states in the EU have led ... medicinal products, the result of which took the shape of ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet’s ... ostomy patients, standing as living proof that attitude and determination can combine into ... issues that spike around the holidays. This campaign will offer patients a new-found ...
(Date:12/2/2016)... ... 02, 2016 , ... Mediaplanet is proud to announce the ... the innovative treatments, therapeutic technologies, and revolutionized nutrition that are helping patients and ... 6 years in the last 3 decades,” says Dr. Valentine Fuster, a world-renowned ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... veterinarian diagnostic imaging systems and the first company to offer robotic ... a Heart at their tradeshow booth # 941 for the American Association of ...
(Date:12/2/2016)... Abilene, Texas (PRWEB) , ... December 02, 2016 , ... ... article that delves into how this current generation fits into Bible Prophecy. Yisrayl says ... lists various facts pointing to this conclusion, showing how the details line up exactly ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... meals to needy individuals and families from eight different sites throughout Miami-Dade and ... Day. Over 1,000 volunteers worked very hard on Thanksgiving morning by putting together ...
Breaking Medicine News(10 mins):